NeuroPace Inc
Provides an implantable neurostimulation system to prevent seizures in drug-resistant epilepsy.
NPCE | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 455 N. BERNARDO AVENUE, 94043 MOUNTAIN VIEW
- Website:
- https://www.neuropace.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
NeuroPace, Inc. is a commercial-stage medical device company focused on transforming the lives of individuals suffering from epilepsy. The company's primary product is the RNS® System, the first and only FDA-approved responsive neurostimulation device. Designed for adults with drug-resistant focal epilepsy, the RNS System is an implantable therapeutic device that continuously monitors brain activity, detects patient-specific abnormal electrical patterns that can lead to seizures, and responds in real-time with imperceptible electrical stimulation to prevent them. In addition to providing personalized treatment, the system collects long-term EEG data, offering physicians unprecedented insights into seizure trends and triggers to help optimize patient care plans.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all NeuroPace Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NeuroPace Inc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NeuroPace Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
